Agate Sensors

Agate Sensors Oy was founded in 2024 in Espoo, Finland, focusing on hyperspectral imaging technology. The company has secured two deals, with the most recent deal occurring on September 2, 2025.6 million. Agate Sensors specializes in ultra-miniaturized hyperspectral imaging technology designed to deliver critical insights across various applications, including health monitoring, defense, and advanced imaging. Their core product offering involves a durable solid-state sensor capable of capturing hundreds of wavelengths with sub-10nm accuracy, enabling the identification of substances and signatures that evade traditional systems. This technology allows for real-time monitoring of vital signs, including continuous blood pressure and biochemical insights, particularly beneficial in wearables.Agate Sensors generates revenue through direct sales of its hyperspectral imaging technology and potential partnership arrangements with various sectors, particularly in healthcare and defense. Transactions typically involve B2B engagements where the company collaborates with manufacturers of wearable devices and defense technology firms. Pricing structures may include tiered pricing for individual units or volume-based agreements, particularly for large-scale deployments of their advanced imaging solutions. The technology's flagship offerings, such as their proprietary hyperspectral sensor, are expected to attract interest from organizations looking to integrate cutting-edge imaging capabilities into their products and services. The company plans to expand its product line with upcoming releases aimed at enhancing healthcare monitoring and defense capabilities while targeting growth in North American and European markets by the end of 2026.

1. Seed

   Sep 2, 2025

   Amount

   $4.7M

   Investors

   Locked